Skip to Main Content
The first stop for professional medicines advice

Primary Care

65 results

Applied filters

SMRs in problematic polypharmacy: anticholinergic burden focus

7 July 2026Expert pharmacists will use a case study to illustrate a patient-centred approach to SMRs for patients on medicines with anticholinergic properties.

Vaccines and immunisation: resources to support clinical decisions

20 May 2026Suggested resources to help healthcare professionals find information regarding medicines and vaccines.

Clozapine use in adults with swallowing difficulties

19 May 2026Guidance on clozapine administration including crushing tablets, importance of not missing doses and practical considerations regarding switching formulations

SMRs in problematic polypharmacy: antimicrobial focus

12 May 2026Expert pharmacists used case studies to illustrate a patient centred approach to SMRs for patients on antimicrobials.

Children's medicines: resources to support clinical decisions

12 May 2026Suggested resources to help primary care healthcare professionals find information on medicines use in children

Primary care discussions: HRT use in clinical practice

24 April 2024This ‘on the couch’ webinar, the second in a series of two, addressed questions around the challenges faced by pharmacists with HRT decision making.

SMRs in problematic polypharmacy: insomnia focus

14 April 2026Expert pharmacists used a case study to illustrate a patient centred and holistic approach to SMRs for patients prescribed medicines for insomnia.

Contraception: resources to support clinical decisions

13 April 2026Suggested resources to help healthcare professionals find information on medicines for contraception and reproductive health

Example medicines to prescribe by brand name

2 April 2026Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Prescribing by generic or brand name

31 March 2026Prescribing medicines by generic name is generally preferred but there are some clinical circumstances when brand-name prescribing is warranted.